Mariner
MIRA icon

Mariner’s MIRA Pharmaceuticals MIRA Stock Holding History

Mariner’s Portfolio MIRA Stock Details MIRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.6K Hold
16,500
– – ﹤0.01% 3490
2026
Q1 		$17.7K Hold
16,500
– – ﹤0.01% 3497
2025
Q4 		$24.9K Hold
16,500
– – ﹤0.01% 3467
2025
Q3 		$22.4K Hold
16,500
– – ﹤0.01% 3507
2025
Q2 		$20K Buy
16,500
+5,000
+43% +$5.77K ﹤0.01% 3422
2025
Q1 		$11.3K Hold
11,500
– – ﹤0.01% 3405
2024
Q4 		$13.1K Buy
+11,500
New +$15K ﹤0.01% 3359

Other funds holding MIRA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CSI
Cross Staff Investments Pittsford, New York $178M AUM 21.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $65.5B AUM 24.25% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
FAB
First American Bank Dundee, Illinois $1.79B AUM 30.35% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Mariner's MIRA Position: Q2 2026 in Review

Mariner held its MIRA Pharmaceuticals (MIRA) position steady in Q2 2026 at 16,500 shares worth $15.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3490.

Mariner first reported a position in MIRA in Q4 2024 and has held it in 7 quarters since. The position peaked at $24.9K in Q4 2025. 26 funds tracked by Wall St. Rank hold MIRA as of Q2 2026.

  • Mariner held 16,500 shares of MIRA Pharmaceuticals worth $15.6K as of Q2 2026.
  • Mariner left its MIRA Pharmaceuticals share count unchanged in Q2 2026.
  • MIRA Pharmaceuticals made up ﹤0.01% of Mariner's portfolio in Q2 2026, its #3490 holding.
  • Mariner first reported a position in MIRA Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • Mariner's MIRA Pharmaceuticals position peaked at $24.9K in Q4 2025.
  • 26 funds tracked by Wall St. Rank held MIRA Pharmaceuticals as of Q2 2026.

Based on Mariner's 13F filing for Q2 2026, filed 13 Aug 2026.